1998 Annual Meeting
Wednesday, June 3


7 a.m.-8:30 a.m.

Industry-Supported Symposium

IS42. Practical Clinical Strategies for Managing Refractory Depression, Agitation, and Antidepressant Side Effects: New Advances in Augmentation and Agitation Treatment Strategies Supported by Bristol-Myers Squibb
A. Augmentation Strategies for the Newer Antidepressants Lauren B. Marangell, M.D.
B. Clinical Pearls in Managing Agitation in the Elderly George T. Grossberg, M.D.

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 77-82

9 a.m.-10:30 a.m.

Clinical Case Conference 3.

Harold E. Broenheim on Psychotherapy With a Patient With Dissociative Identity Disorder (Open to APA members only.)

Discussion Groups

9. Mark H. Townsend, M.D., on The Treatment of Lesbians and Gay Men: Are the Psychiatric Issues Really Different? (for residents only)
10. Stephen J. Ferrando, M.D., on Substance Use Disorders and HIV Infection in 1998: Where Are We With Prevention and Treatment? Collaborative Session With the National Institute on Drug Abuse

Lectures

L19. The Convergence of Neurobiology and Psychodynamics Maurice H. J. Dongier, M.D., Distinguished Psychiatrist Lecture Series
L20. Immigration and Psychopathology: Is There a Connection? Javier I. Escobar, M.D., APA's Simon Bolivar Award Lecture
L21. Spiritual and Religious Issues in Psychopathology and Psychotherapy Allen E. Bergin, Ph.D., APA's Oskar Pfister Award Lecture

Master Educator Clinical Consultations

10. Jon M. Streltzer, M.D., on Evaluation and Management of Chronic Pain Patients With and Without Medication Dependence (Open to APA members only.) 11. Marc Galanter, M.D., on Effective Engagement of the Substance Abuser in Office Practice; Collaborative Session With the National Institute on Drug Abuse (Open to APA members only.) 12. Bonnie T. Zima, M.D., on Assessing the Need for Mental Health Services Among High-Risk Children (Open to APA members only.)

New Research Oral/Slide Sessions

Component Workshops

CW37. Navajo Psychology APA Committee of American Indian/Alaska Native and Native Hawaiian Psychiatrists and APA Council on National Affairs Co-Chairpersons: Mary H. Roessel, M.D., and Edward J. Neidhardt, M.D
. CW38. Coding Changes and New Documentation Requirements APA Work Group on Codes and Reimbursements and APA Work Group on Harvard Resource-Based Relative Value Scale Study Chairperson: Chester W. Schmidt Jr., M.D
.. CW39. Physicians Under Fire: Understanding and Help APA Committee on Physician Health, Illness, and Impairment Co-Chairpersons: Stephen L. Dilts, M.D., and Malkah T. Notman, M.D.
. CW40. The Experience of Coming Out in Psychiatry APA Southern California Psychiatric Society's Committee on Gay, Lesbian, and Bisexual Issues Chairperson: Nick M. Gutierrez, M.D.
. CW41. The Search Committee and Issues for Women APA Committee on Women Chairperson: Donna E. Stewart, M.D.
.

Issue Workshops

IW62. IMG's in the United States: Problem or Solution? Co-Chairpersons: Renato D. Alarcon, M.D., and Alejandra Hallin, M.D.
. IW63. Spirituality/Religion in the Medical School Curriculum Chairperson: Francis G. Lu, M.D.
. IW64. Psychiatric Assessment of Juvenile Dangerousness Chairperson: Charles L. Scott, M.D.
. IW65. ABPN Update: Requirements for the ABPN Examination Joint Session With the American Board of Psychiatry and Neurology Inc. Chairperson: Stephen C. Scheiber, M.D.
. IW66. The Occurrence of Dissociative Identity Disorder in Psychiatric Inpatients Chairperson: Arthur Rifkin, M.D.
. IW67. When a Medical Student Commits Suicide Co-Chairpersons: Donald A. Misch, M.D., and Stewart A. Shevitz, M.D.
. IW68. Psychiatry, Euthanasia, and Assisted Suicide Co-Chairpersons: Leigh C. Bishop, M.D., and Samuel B. Thielman, M.D.
. IW69. Testimony: A Former Political Prisoner From Haiti Joint Session With the Haitian-American Psychiatric Association Chairperson: Jacques Vital-Herne, M.D.
. IW70. Challenges in Resocializing Psychiatric Education Chairperson: Kenneth S. Thompson, M.D
.. IW71. Cultural Issues in the Psychiatric Patient Chairperson: Cletus S. Carvalho, M.D
.. IW72. Punk Prisons and Juvenile Justice Reform in the 1990's Chairperson: James E. Dillon, M.D.
. IW73. ATOD-TV (Alcohol, Tobacco, and Other Drugs) and Community Attitudes Regarding Drug Abuse Collaborative Session With the National Institute on Drug Abuse Chairperson: Tim Condon, Ph.D.
. IW74. Disabled Doctors: Insurers Seek a Second Opinion Chairperson: Kenneth L. Appelbaum, M.D.
. IW75. White House Cases: Risk Assessment and Management Chairperson: Robert T. M. Phillips, M.D., Ph.D.
. IW76. Advocacy: Reaching the Media on Mental Health Chairperson: Edward B. Gogek, M.D.
. IW77. Privacy or Reimbursement? An Unexpected Choice Co-Chairpersons: Kathleen C. Dougherty, M.D., and Kenneth M. Certa, M.D.
. IW78. Gay Psychiatrists: An Amsterdam Perspective Chairperson: Nicolaas F.J. Hettinga, M.D.
. IW79. Community Therapy: Treatment for Severe BPD Co-Chairpersons: Glenn N. Siegel, M.D., and Mary J. Pittman, M.S.
.

9 a.m.-Noon

Media Session

Session 20. The Internet and Psychotherapy 37. Psychotherapy on the Internet
38. Cytochrome Interactions via the Web
39. Computer-Assisted Psychotherapy

9 a.m.-11 a.m.

Media Sessions

Session 21. Prevention of Substance Abuse Collaborative Session With the National Institute on Drug Abuse
40. Prevention of Substance Abuse Risk for Families at Risk

Session 22. Healing From Grief: Child and Parent Losses
41. A Mother's Grief
42. Grown-Up Tears

Practice Guidelines Update

Practice Guidelines: Delirium and HIV/AIDS
APA Steering Committee on Practice Guidelines Co-Chairpersons: John S. McIntyre, M.D., and Deborah A. Zarin, M.D.

9 a.m.-Noon

AIDS Education Program

AIDS Among Special Patient Populations, Part II
Cosponsored by the APA Commission on AIDS and APA Education Steering Committee on AIDS
A. Special Issues of Women With AIDS and HIV Disease Cheryl J. Rowe, M.D.
. B. Children and Adolescents Arlette M.L. Lefebvre, M.D.
. C. Multicultural Issues in HIV/AIDS Care Joyce Y. Chung, M.D.
.

Presidential Session

A Time of Violence: Part I on Juvenile Justice Chairperson Lawrence A. Stone, M.D.

Social Security Workshop

Disability Evaluation Under Social Security: A Presentation for Treating Psychiatrists
Sponsored by the Social Security Administration, APA Office of Psychiatric Services, and APA Consortium on Organized Service Systems Chairperson: Jerome E. Shapiro, M.D.

9 a.m.-12:30 p.m.

Review of Psychiatry, Part IV: Interpersonal Therapy

Chairperson: John C. Markowitz, M.D.
. 16. Interpersonal Psychotherapy: An Overview Myrna M. Weissman, Ph.D.
. 17. Maintenance Interpersonal Psychotherapy: A Preventive Treatment for Depression Cynthia Spanier, Ph.D.
. 18. Interpersonal Psychotherapy for the Treatment of Depression in HIV-Positive Men and Women Holly A. Swartz, M.D.
. 19. Interpersonal Psychotherapy for Depressed Adolescents Laura Mufson, Ph.D.
. 20. Interpersonal Psychotherapy for Patients With Bulimia Denise E. Wilfley, Ph.D.
.

9 a.m.-4 p.m.

CME Courses 83-88

10 a.m.-3 p.m.

Exhibits Open (last day)

Publishers' Bookfair Open (last day)

APA Resource Center Open (last day)

11 a.m.-2 p.m.

Media Sessions

Session 23. Innovative Community Approaches for the Homeless
43. Straight Dope
44. The Dark Side of the Moon

Session 24. DSM-IV New Diagnostic Issues
45. Psychotic Disorders
46. Anxiety Disorders
47. Mood Disorders

11 a.m.-12:30 p.m.

Discussion Groups

11. Jimmie C. Holland, M.D. (Topic to Be Announced) .
12. Edward F. Foulks, M.D., on How to Participate in Mental Health Advocacy Organizations

Lecture

L22. To Be announced Joseph LeDoux, Ph.D., Frontiers of Science Lecture Series

Master Educator Clinical Consultation

13. Marvin I. Herz, M.D. (Topic to Be Announced) (Open to APA members only.)
14. Michael H. Sacks, M.D., on Inpatient Management of Comorbid Axis II Disorders (Open to APA members only.)
15. James E. Dillon, M.D., on Antisocial Behavior Through the Life Cycle: Clinical and Forensic Issues (Open to APA members only.)

Medical Update 3.

Norman Sussman, M.D., on The Hepatic Cytochrome P450 System

Research Consultation With

2. Kenneth B. Wells, M.D., on Developing a Career/Program/Grant in Mental Health Services Research

Scientific and Clinical Report Sessions

Session 20. Challenging Clinical Issues in Schizophrenia 59. Schizophrenia: A Language or Thought Disorder? Martin Harrow, Ph.D.
. 60. Suicide Attempts in Schizophrenia: Demoralization or Depression? Kathleen Restifo, Ph.D.
. 61. Predictors of Schizophrenia Matti K. Isohanni, M.D.
.

Session 21. Psychopharmacology 62. Olanzapine: Safe in Clozapine-Induced Agranulocytosis L. Kola Oyewumi, M.D.
. 63. Sildenafil for Erectile Dysfunction: A One-Year Study Waguih R. Guirguis, M.D.
. 64. Adverse Event Profiles Associated With Long-Term Fluoxetine Treatment Roy Tamura, Ph.D.
.

Session 22. Mental Health Stresses in Children 65. Psychological Functioning and Child Abuse in Adolescents Charles Sanislow, Ph.D
.. 66. Clinical Judgment in Reports of Childhood Sexual Abuse Cheryl Gore-Felton, Ph.D.
. 67. Homeless Children: Stressors and Mental Health Problems Bonnie T. Zima, M.D.
.

Session 23. Brain Imaging 68. Basal Ganglia Choline Levels in True Drug Response Maurizio Fava, M.D
.. 69. Neuroanatomy of Attention to Emotional Experience Richard D. Lane, M.D.
. 70. Atrophy and Metabolite Abnormality in Movement Disorder Subhendra Sarkar, Ph.D.
.

Session 24. Bipolar Group: At-Risk Population 71. Which Unipolar Depressives Are Really Bipolar? Joseph F. Goldberg, M.D.
. 72. Postpartum Course of Bipolar Illness Ruta M. Nonacs, M.D.
. 73. Treatment of Bipolar Spectrum Symptoms Ronald A. Rabin, M.D.
.

Session 25. Treatment Issues in Anxiety Disorders 74. Cognitive and/or Behavioral Therapy in Social Phobia Jean A. Cottraux, M.D.
. 75. The Association Between Symptom Changes and Clinical Outcome in Panic Disorder David Michelson, M.D.
. 76. Platelet and Plasmatic MAO in Anxiety Disorders Oscar R. Carrion, M.D.
.

Session 26. Diagnosis and Methodology in Personality Disorders 77. Divalproex for Aggression in Personality Disorders Richard J. Kavoussi, M.D.
. 78. Internal Consistency and Overlap of DSM-IV Personality Disorders Carlos M. Grilo, Ph.D.
. 79. Identifying Personality Disorders: Toward the Development of a Clinical Screening Instrument H. George Nurnberg, M.D
..

Session 27. Forensic Psychiatry 80. Psychiatric Disability Exam for Employment Discrimination and the Americans With Disabilities Act Lauren J. Wylonis, M.D.
. 81. The Effect of Depression on Competency: A Survey Kevin C. Hails, M.D.
. 82. Malpractice Law and Managed Care: New Developments Eugene L. Lowenkopf, M.D.
.

Session 28. Psychiatric Epidemiology 83. Prevalence of Dementia in Centenarians Ben A. Blansjaar, M.D.
. 84. Is Schizophrenia on the Decline? Carolyn M. Woogh, M.D.
. 85. A Prospective Analysis of Alcohol Use Disorders Rosa Maria Crum, M.D.
.

Session 29. The Wide World of Neuropsychiatry 86. Drug-Induced Delirium in Intensive Care Units Kwo-Hwa Tseng, M.D.
. 87. Role of Sympathoadrenal Dysfunction in Hyperthermia Ronald J. Gurrera, M.D.
. 88. Epilepsy and Psychosis: A Neurodevelopmental Hypothesis Anthony Feinstein, M.D.
.

Component Workshops

CW42. How to Launch a Successful Private Practice APA Assembly's Committee of Area Early Career Psychiatrists and APA Committee of Early Career Psychiatrists Chairperson: William E. Callahan Jr., M.D.
CW43. Psychiatric Training at Home and Abroad APA Council on International Affairs Chairperson: Daniel A. Monti, M.D.
CW44. Clinical Assessment Management of Sexual Harassment: 1998 Update APA New Jersey Psychiatric Association's Committee on Women Co-Chairpersons: Rita R. Newman, M.D., and Angela M. Hegarty, M.D.
CW45. The Americans With Disabilities Act and the Recovering Physician APA Committee on Training and Education in Addiction Psychiatry Chairperson: Jonathan I. Ritvo, M.D.
CW46. Risk Management Issues in Psychiatric Practice APA Psychiatrists' Purchasing Group Inc. Chairperson: Alan I. Levenson, M.D.
CW47. Spiritual and Religious Issues in Mental Health and Illness APA Committee on Religion and Psychiatry and APA Council on National Affairs Co-Chairpersons: George T. Harding IV, M.D., and Rev. Clark S. Aist, Ph.D.
CW48. Being Afraid: When Trainees Fear for Their Safety APA Committee of Residents and Fellows Co-Chairpersons: Derek G. Puddester, M.D., and Zachary Solomon, M.D.
CW49. Cultural Outcomes in the Elderly: An Industry Perspective APA Committee on Ethnic Minority Elderly Chairperson: Jacobo E. Mintzer, M.D.

Issue Workshops

IW80. Avoiding Admission: Psychiatric Home Care Chairperson: David S. Heath, M.B.
IW81. Developing Alternatives to Outpatient Commitment Chairperson: Roger L. Coleman, M.D.
IW82. Involuntary Case Management for the Mentally Ill Chairperson: Howard W. Telson, M.D. .
IW83. When Clozapine Alone Is Not Enough Chairperson: Jean-Pierre Lindenmayer, M.D. .
IW84. Group Therapy: Making Untreatable Patients Treatable Joint Session With the American Group Psychotherapy Association Inc. Co-Chairpersons: C. Donald Williams, M.D., and Miguel A. Leibovich, M.D.
. IW85. Workforce and Recruitment: We Can Make a Difference Co-Chairpersons: Francis G. Lu, M.D., and Lisa A. Mellman, M.D. .
IW86. Leadership: The Challenge for the 21st Century Co-Chairpersons: Edgardo L. Perez, M.D., and Diane K. Whitney, M.D. .
IW87. Cultural Issues in Psychiatric Training and Practice Chairperson: Cletus S. Carvalho, M.D.
. IW88. Becoming a Psychiatrist in the New Millennium Chairperson: Daniel P. Dickstein, M.D. .
IW89. Spirituality, Faith, and Mental Health: An Islamic View Joint Session With the World Islamic Association of Mental Health Chairperson: S. Arshad Husain, M.D. .
IW90. Psychotherapy in the 21st Century Chairperson: Malkah T. Notman, M.D. .

Noon-1:30 p.m.

Forums

7. Trust in Human Subject Research Chairperson: John M. Oldham, M.D. .
8. The Impact of American Psychiatry on the Development of Psychiatry in Asia APA's Kun-Po Soo Award Chairperson: Robert O. Pasnau, M.D. .
9. Who Will Pay for the Treatment of Substance Abuse? Collaborative Session With the National Institute on Drug Abuse Chairperson: Roger E. Meyer, M.D. .

Noon-2 p.m.

New Research Poster Session

12:30 p.m.-2 p.m.

Media Sessions

Session 25. Noon Jazz Festival
48. Can't You Hear the Wind Howl?

1 p.m.-4 p.m.

Session 26. Computerized Medical Records/Practice Management Software: Part III

49. Booting Up Your Practice
50. A Computer Assessment Using Scores and Narratives
51. Relational Database in Clinical Practice

1 p.m.-5 p.m.

CME Courses 89-92

2 p.m.-3:30 p.m.

Lectures

L23. Cocaine and the Addicted Brain Nora D. Volkow, M.D., Frontiers of Science Lecture Series Collaborative Session With the National Institute on Drug Abuse
L24. The Empty Self: BPD in Historical Perspective Elizabeth Lunbeck, Ph.D., APA's Benjamin Rush Award Lecture.

2 p.m.-5 p.m.

Media Sessions

Session 27. Substance Abuse: Global and Historical Perspectives
52. Dealing With the Demon: A Three-Part Series

Session 28. Childhood Issues
53. Healing Wounded Hearts
54. When the Bough Breaks
55. Breaking the Cycle

Presidential Session

A Time of Violence: Part II on Intergroup Violence Chairperson Alan A. Stone, M.D.

2 p.m.-5:30 p.m.

Review of Psychiatry, Part V: Psychological Trauma: Prevalence, Course, Psychobiology, and Treatment

Chairperson: Rachel Yehuda, Ph.D
.. 21. Epidemiology of Trauma and PTSD Naomi Breslau, Ph.D.
. 22. Longitudinal Development of Post-Traumatic Disorders Arieh Y. Shalev, M.D.
. 23. Evaluating the Effects of Psychological Trauma Using Neuroimaging Techniques Scott L. Rauch, M.D.
. 24. Neuroendocrinology of Trauma and PTSD Rachel Yehuda, Ph.D.
. 25. Psychosocial Treatments for PTSD Edna B. Foa, Ph.D.
. 26. Pharmacotherapy of PTSD Randall D. Marshall, M.D
..

2 p.m.-5 p.m.

Symposia

S59. Outcome Measurement in Psychiatry: A Critical Review
A. Outcome Measurement: Definition, History, and Review of Available Tools Waguih W. Ishak, M.D.
. B. The Ideal Outcome Measurement Tool Susan Eisen, Ph.D.
. C. Critical Appraisal of Different Outcome Measurement Tools Jean Endicott, Ph.D.
. D. Implementing Outcome Assessment in a Clinical Facility Lloyd I. Sederer, M.D.
. E. Outcome Measures: Computers, Managed Care, and Rehabilitation Zebulon C. Taintor, M.D.
.

S60. Clinical Subtyping of Schizophrenia
A. Associated Syndromes in Chronic Schizophrenia Paul C. Bermanzohn, M.D.
. B. Is There Room for a Schizo-Obsessive Subtype? Joseph Zohar, M.D.
. C. How Vulnerable Are Schizophrenia Patients to Depression? Martin Harrow, Ph.D.
. D. Antidepressants and Benzodiazepines in Schizophrenia Samuel G. Siris, M.D.
. E. Is Panic a Schizophrenia Subtype? Paul C. Bermanzohn, M.D.
.

S61. Anxiety Spectrum Disorders: A New Millennium
A. The Anxiety Spectrum and the Obsessive-Compulsive Spectrum Eric Hollander, M.D.
. B. New Findings in the Neurobiology and Treatment of Panic Jack M. Gorman, M.D.
. C. Social Phobia: Part of a Shyness Spectrum? Murray B. Stein, M.D.
. D. PTSD Joseph Zohar, M.D

.. E. Diagnosing and Treating Coexisting Anxiety and Depression Norman Sussman, M.D.
.

S62. Juvenile Offenders: Modern Issues for Child Psychiatry
A. A Systems Approach to Mental Health in Juvenile Facilities William M. Womack, M.D.
. B. Teaching Clinical Skills to Correction Staff: A Necessity, Not an Option Lisa M. Boesky, Ph.D.
. C. Suicidal and Self-Mutilating Behavior in Incarcerated Adolescents Jana Ewing, Ph.D.
. D. Treatment of Traumatic Bereavement With Incarcerated Youth Edward K. Rynearson, M.D.
.

S63. Detection and Treatment of Stimulant Abuse
Collaborative Session With the National Institute on Drug Abuse A. Detection of Stimulant Abuse Jeffery N. Wilkins, M.D
.. B. Psychosocial Treatment for Stimulant Abusers Douglas M. Ziedonis, M.D.
. C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.
. D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.
. E. Methamphetamine Abuse: New Developments Steven L. Batki, M.D.
.

S64. The Relationship Between Seasonality, Eating, and Mood
A. Serotonin Dysfunction in Bulimia and SAD Robert D. Levitan, M.D.
. B. Seasonality of Mood and Eating in Bulimia and SAD Allan S. Kaplan, M.D.
. C. Comorbidity of SAD and Bulimia in a Clinic and Community Sample Anthony J. Levitt, M.D.
. D. Bulimia Nervosa and SAD: Overlapping Treatment Raymond W. Lam, M.D.
.

S65. Personality Disorders Research in Canada
A. The Etiology of Personality Disorder Traits John Livesley, M.D.
. B. Prospective Follow-Up of Borderline Personality: Mechanisms of Change Paul S. Links, M.D.
. C. Implications of Research on Psychological Risk Factors in BPD Joel F. Paris, M.D.
. D. Risk Factors for Borderline Pathology in Children Jaswant Guzder, M.D.
. E. Defenses in Personality and Depressive Disorders J. Christopher Perry, M.D.
.

S66. Dynamic Perspectives on Treatment Resistance
A. Treatment Resistance and the Dynamics of the Dual Treatment Relationship James M. Ellison, M.D.
. B. Readiness for Change in Treatment Resistance Barri A. Belnap, M.D.
. C. Enactment and Treatment-Refractory Depression Eric M. Plakun, M.D.
. D. Treatment Resistance: A Cognitive-Behavioral Perspective Michael E. Thase, M.D
..

S67. Pathways to Homelessness
A. An Integrative Approach to Research With Homeless Persons George S. Tolomiczenko, Ph.D.
. B. Prevalence of Mental Illness Among Homeless Persons Donald A. Wasylenki, M.D.
. C. Pathways Into First-Time Homelessness Paula N. Goering, Ph.D.
. D. Neuropsychological and Personality Factors George S. Tolomiczenko, Ph.D.
. E. HIV Prevalence and Risk Factors in an Adult Homeless Population Mark H. Halman, M.D.
.

S68. Psychosocial Aspects of HIV Risk Among Young IV Drug Users
A. Overview of the Collaborative Injection-Drug Users Study (CIDUS II) Edgar Monterroso, M.D.
. B. Psychopathology and HIV Risk Behavior Among Young Injection-Drug Users Patricia Simon-Morse, Ph.D
.. C. Injection-Drug Users and HIV Risk in Chicago Demographics and Gang Behavior Lorna Thorpe, M.P.H.
. D. Violence, Trauma, and HIV Among Young Injection-Drug Users Nance Sohler, Ph.D.
.

S69. The Many Faces of the Drug Problem
Joint Session With the InterAmerican Council of Psychiatric Organizations A. Substance Abuse: A Vision From the United States Pedro Ruiz, M.D
.. B. Substance Abuse: A South-American Perspective Carlos Leon-Andrade, M.D.
. C. The International Drug Trafficking Roberto E. Chaskel, M.D.
. D. Substance Abuse and HIV/AIDS: A Problem for the Americas Rodolfo D. Fahrer, M.D.
. E. Substance Abuse: A Caribbean Perspective Sharon C. Harvey, M.D.
.

S70. Doctors and Drug Companies: Unholy Alliance or Match Made in Heaven?
A. Promotion in the Guise of Education Irwin N. Hassenfeld, M.D.
. B. The Developmental History of a Pharmaceutical Lecture Joseph Di Giacomo, M.D.
. C. Psychology and Ethics of Giving and Receiving Carl Mindell, M.D.
. D. Organizational Perspective on Industry Support Carolyn B. Robinowitz, M.D.
.

S71. Medication: Changing a Person or Treating a Patient?
A. Stability of Personality Disorders With Treatment for Chronic Depression Robert M.A. Hirschfeld, M.D.
. B. Does Medication Change Personality Organization? Carlos Blanco, M.D.
. C. Defense Mechanisms and Axis I: Searching for Stability Linda S. Mullen, M.D.
. D. Biological Studies in Personality Disorders Emil F. Coccaro, M.D.

.

S72. Herbal Medicine: Ancient Roots to Modern Use
A. Herbal Medicine and Psychiatry: Potential for Toxicity Michael W. Smith, M.D.
. B. Kava: Ancient Beverage to Modern Psychotherapeutic Medicine Dennis J. McKenna, Ph.D.
. C. Antidepressant Activity of Hypericum Perforatum: St. John's Wort Jerry M. Cott, Ph.D.
. D. Plant Entheogens as Medicine Charles S. Grob, M.D.
.

S73. Classic and Atypical Neuroleptics in Dementia
A. A Neurochemical Rationale for the Use of Neuroleptics in Dementia Dario F. Mirski, M.D.
. B. Classic Neuroleptics in Dementia Davangere P. Devanand, M.D.
. C. Atypical Neuroleptics in Dementia S. Craig Risch, M.D.
. D. Efficacy and Safety of Atypical Neuroleptics in Dementia Jacobo E. Mintzer, M.D.
.

S74. Catatonia and Other Motor Syndromes: How Closely Related?
A. Diagnostic and Therapeutic Relevance of Catatonia Brendan T. Carroll, M.D.
. B. Catatonia and Noncatatonic Motor Syndromes in Schizophrenia Peter Braunig, M.D.
. C. Similarity of Catatonia and NMS Andrew J. Francis Jr., M.D.
. D. Prevalence and Clinical Significance of Catatonic Symptoms in Mania Stephanie Kruger, M.D.
. E. Neurological Soft Signs in Schizophrenia Subtypes Oliver Rommel, M.D.
.

S75. Practice Profile of United States and Canadian Psychiatrists Joint Session With the Canadian Psychiatric Association A. Practice Profile Survey by the Canadian Psychiatric Association: Study, Design, and Results D. Blake Woodside, M.D.
. B. Findings From the American Psychiatric Association's Practice Research Network Study of Psychiatric Patients and Treatments Harold Alan Pincus, M.D.
. C. The Practice Profile Study by the Canadian Psychiatric Association: Methodological Issues Elizabeth Lin, Ph.D.
. D. The American Psychiatric Association's Practice Research Network Study of Psychiatric Patients and Treatments: Methodological Issues Deborah A. Zarin, M.D.
. E. Canadian Human Resource Surveys: Policy Implications Nady El-Guebaly, M.D.
. F. The American Psychiatric Association's Practice Research Network Study of Patients and Treatments: Policy Implications John S. McIntyre, M.D.
.

S76. Psychiatric Aspects of Epilepsy
A. Diagnosis and Outcome of Psychogenic Nonepileptic Events Andres Kanner, M.D.
. B. Brain SPECT in Paroxysmal Psychiatric Episodes Thomas H. Jobe, M.D.
. C. Treatment of Psychogenic Nonepileptic Events Prema V. Sanne, M.D.
. D. Lamotrigine in the Treatment of Epileptic Psychosis Ovidio A. De Leon, M.D.
.

S77. New Anticonvulsants in Mood Disorders: An Update
A. Pharmacology and Pharmacokinetics of New Anticonvulsants Terence A. Ketter, M.D.
. B. Lamotrigine in Bipolar Disorder Joseph R. Calabrese, M.D.
. C. An Open Trial of Gabapentin in Bipolar Disorder L. Trevor Young, M.D.
. D. Gabapentin and Lamotrigine Monotherapy in Mood Disorder: An Update Mark A. Frye, M.D.
. E. Neuroimaging of Response to Lamotrigine and Gabapentin Timothy A. Kimbrell, M.D.
.

S78. Collaborative Study of Personality Disorders
A. An Overview of the Study and the Sample John G. Gunderson, M.D
.. B. Diagnostic Interview for DSM-IV Personality Disorders: Test-Retest and Interrater Reliability Mary C. Zanarini, Ed.D.
. C. Functional Impairment in Four Personality Disorder Types Andrew E. Skodol II, M.D.
. D. Axis II Comorbidity of DSM-IV Personality Disorders Carlos M. Grilo, Ph.D.
. E. Stability of Personality Disorder: Diagnoses and Criteria M. Tracie Shea, Ph.D
. F. Dimensions and Categories in Personality Disorder Leslie C. Morey, Ph.D.
.

S79. Current Trends in Russian Psychiatry
A. Development of Russian Psychiatry: Current Condition and Trends Valery N. Krasnov, M.D.
. B. Economic Research Program in Russian Psychiatry Vassiey Yastrebov, M.D.
. C. Psychiatric Care in Russia: Situation and Perspectives Isaac Ya. Gurovich, Ph.D.
. D. Russian Psychiatry and the Law: Facts and Problems Svetlana Polubinskya
. E. Alcohol and Substance Abuse Disorders in Russia for the Last Two Decades (1976-1996) Alexander V. Nemtsov, Ph.D
.. F. Biological Treatment of Mental Disorders in Russia Sergey N. Mosolov, M.D.
. G. Criteria of Depression in General Somatic Practice Olga P. Vertogradova, Ph.D.
.

S80. Medications Development for Substance Dependence Collaborative Session With the National Institute on Drug Abuse
A. Targeted Subgroups for Cocaine Pharmacotherapies Thomas R. Kosten, M.D.
. B. Targets for Medication to Prevent Relapse Charles P. O'Brien, M.D.
. C. Levomethadyl Acetate Hydrochloride and Buprenorphine Treatment Eric C. Strain, M.D.
. D. Cocaine Pharmacotherapy: Human Laboratory Studies Marian W. Fischman, Ph.D.
. E. Pharmacotherapy for Opiate and Stimulant Dependence Frank J. Vocci, Ph.D.
.

S81. Hormones and Depression: Treatment Implications
A. Testosterone and Male Depression: A Clinical Review Stuart N. Seidman, M.D.
. B. Exogenous DHEA and Antiglucocorticoids in Depression Victor I. Reus, M.D.
. C. Estrogen and Depressive Disorders in Women Mary F. Morrison, M.D.
. D. Thyroid Hormones and Mood Disorders Gregory M. Sullivan, M.D.
.

S82. Psychiatric Ethics: Facing the 21st Century
A. Misuse and Abuse of Psychiatry: A 50-Year Overview Paul Chodoff, M.D.
. B. Professional Boundaries in Psychiatry Glen O. Gabbard, M.D.
. C. The Ethics of Managed Mental Health Care Stephen A. Green, M.D.
. D. The Ethics of For-Profit Managed Care Is an Oxymoron Leon Eisenberg, M.D.
. E. Codes of Ethics and Psychiatry Sydney Bloch, M.D.
.

S83. Estrogen, Progesterone, Testosterone, and Dysphoria
A. Estrogen and Testosterone: Natural Antidepressants? Susan Rako, M.D.
. B. Menopause, Mood, MAO, and Hormone Replacement Edward L. Klaiber, M.D.
. C. Sex Therapy in Women With Testosterone Deficiency Barbara D. Bartlik, M.D.
.

S84. Cutting-Edge Polypharmacy for Mood Disorders
A. Switching Strategies in Refractory Depression Maurizio Fava, M.D.
. B. Lithium Augmentation of the Newer Antidepressants Andrew A. Nierenberg, M.D.
. C. The Use of Pindolol to Potentiate Antidepressant Medication Pierre Blier, M.D.
. D. Rational Polypharmacy for Refractory Bipolar Disorder Andrew L. Stoll, M.D.
. E. Inositol: A Novel Augmentation for Mood Disorders Robert H. Belmaker, M.D.
.

S85. Oklahoma City: Trauma and Renewal After Terrorism
A. Terrorism and Community Resilience Robert Vincent, Ph.D
.. B. Terrorism Impacts Oklahoma City Students Sandra Allen, Ph.D
.. C. Traumatic Bereavement in Mothers and Grandmothers Suzanne W. Whittlesey, R.N.
. D. Trauma and Recovery in Highly Exposed Adults Phebe M. Tucker, M.D.
. E. Resiliency in Oklahoma City Fire Fighters Sara Jo Nixon, Ph.D.
.

S86. Societal and Cultural Adaptations to Trauma
A. Does Vengeance Heal Psychic Trauma? James Gilligan, M.D
.. B. Individual and Communal Recovery in Bosnia-Herzegovina Judith L. Herman, M.D.
. C. Violence Turns Me On: Nazi Skinhead Adolescents in Germany Annette Streeck-Fischer
. D. Human Rights Abuses in Turkey: Examples and Challenges Sahika Yuksel, M.D.
. E. After Apartheid: South Africa's Truth and Reconciliation Merle Friedman

3 p.m.-5 p.m.

New Research Poster Session

4 p.m.-5 p.m.

Media Session

Session 29. Computer Production Workshop

7 p.m.-10 p.m.

Industry-Supported Symposia

IS43. Neurocognition in Schizophrenia Supported by Janssen Pharmaceutica and Research Foundation
. A. Neurocognitive Deficits in Schizophrenia: Traits or States? Keith Nuechterlein, Ph.D.
. B. Neurocognitive Considerations for Functional Outcome Michael F. Green, Ph.D.
. C. Spatial Working Memory in Schizophrenia Susan R. McGurk, Ph.D.
. D. Cognitive Changes With Aging in Schizophrenia Philip D. Harvey, Ph.D.
. E. Cognitive Deficits in First-Episode Schizophrenia Lili C. Kopala, M.D.
. F. Impact of Antipsychotic Pharmacotherapy on Neurocognition William C. Wirshing, M.D
..

IS44. Management of Mental Disorders in Baby Boomers and Beyond Supported by Pfizer U.S. Pharmaceutical
.s A. Aging and Adaptation to Life and Illness: A Psychiatric Perspective George E. Vaillant, M.D.
. B. Late-Life Depression Donald P. Hay, M.D.
. C. Anxiety, Agitation, and Insomnia Carl Salzman, M.D.
. D. Interface of Depression and Medical Illness Richard C. Veith, M.D.
. E. Behavioral Symptoms of Alzheimer's and Other Dementias Sanford I. Finkel, M.D.
.

IS45. Predicting Outcomes of Antidepressant Treatment Supported by Pharmacia & Upjohn Company Inc.
. A. Clinical Predictors of Response to Antidepressants Andrew A. Nierenberg, M.D.
. B. Neurophysiologic Predictors of Treatment Response Ian A. Cook, M.D.
. C. Neurotransmitter Depletion and Outcome in Depression Pedro L. Delgado, M.D.
. D. Neuroimaging Indicators of Treatment Effectiveness Harold A. Sackeim, Ph.D.
. E. Differential Therapeutic Responses in Depression Andrew F. Leuchter, M.D.
.

IS46. Therapeutic Challenges in Geriatric Psychiatry Supported by Forest Laboratories Inc.
. A. Diagnosis and Biology of Late-Life Depression and Dementia P. Murali Doraiswamy, M.D.
. B. The Management of Anxiety in Late Life Alastair J. Flint, M.B.
. C. Treatment-Resistant Depression in Late Life Benoit H. Mulsant, M.D.
. D. Comorbid Dementia and Depression in Late Life Barnett S. Meyers, M.D.
. E. Behavioral Disturbances of Dementia Bruce G. Pollock, M.D.
.

IS47. Practical Alzheimer's Disease Management: A Comparative Review of New Compounds, Diagnosis, Treatment, and Outcomes Assessment Supported by Eisai Inc. and Pfizer Inc.
. A. Recognition of Alzheimer's Disease: The Importance of Early Diagnosis to Desirable Patient Outcomes Rachelle Doody, M.D.
. B. Pathogenesis of Alzheimer's Disease Jeffrey L. Cummings, M.D.
. C. Cognitive Enhancement in Alzheimer's Disease: A Comparative Review of New and Emerging Therapies Trey Sunderland, M.D.
. D. Treating Behavioral Manifestations in Patients With Alzheimer's Disease: Differential Diagnosis and Therapies David L. Sultzer, M.D.
. E. Assessing Alzheimer's Disease Treatment Response: Outcome Strategies for the Office Practice Ira R. Katz, M.D.
. F. Why Treat? The Economic Impact of Early Diagnosis and Effective Treatment of Alzheimer's Disease Peter J. Neumann, Sc.D.
.

Media Sessions

Session 30. Japanese and Vietnamese Stories of Trauma and Recovery
56. Momiji: Japanese Maple 57. Kim's Story: The Road From Vietnam 58. The Shot Heard Round the World

Session 31. Psychiatric Perspectives on Race and Boxing Joint Session With the International Society for Sport Medicine
59. When We Were Kings: The Untold Story of the Rumble in the Jungle

Symposia

S87. The Role of Coercion in Psychiatry
A. Coercion of Motivation: General Issues Naomi B. Heller, M.D.
. B. The History of Involuntary Treatment John P. Shemo, M.D.
. C. History of Involuntary Treatment of Those With Addiction William W. Van Stone, M.D.
. D. Role of Coercion in Hospital Management Lynn DeLacy, M.S.
. E. Role of Coercion in Treatment of the Homeless Mentally Ill Lien A. Hung, M.D.
.

S88. Finding the Person in Writing About Patients
A. Katherine Holden: A Patient Jeanne L. Steiner, D.O.
. B. The Reunion Jaak Rakfeldt, Ph.D
.. C. On Rounds in a Psychiatric Hospital Dolly D. Jacobson, M.S.W.
. D. Jorge's Story Carole T. Goldberg, Ph.D.
. E. The Portrait Charles D. Atkins, M.D.
.

S89. French and American: Vive La Difference!
A. Is There a Cultural Psychiatry in France? Jean-Charles Pascal, M.D.
. B. Is There a Cultural Psychiatry in America? Rodrigo A. Mu-oz, M.D.
. C. The Treatment of Substance Abuse in France Simon-Daniel Kipman, M.D.
. D. The Treatment of Substance Abuse in America Robert B. Millman, M.D.
. E. A Day in the Life of a French Psychiatrist With a Liberal Practice Jean-Michel Thurin, M.D.
. F. A Day in the Life of a Psychiatrist in America Robert Michels, M.D.
.

S90. Music Therapy in Psychiatric Care
A. Music Therapy and Psychiatry: An Overview John S. McIntyre, M.D.
. B. Music Therapy for an Aging Population David S. Smith, Ph.D.
. C. Music Therapy for Short-Term Inpatient Psychiatric Treatment Carol L. Shultis, M.Ed.
. D. Music-Assisted Cognitive-Behavioral Interventions Thomas H. Kerr, M.A.
. E. Reimbursement for Music Therapy Services Bryan C. Hunter, Ph.D.
.

S91. Computer-Assisted Psychotherapy
A. Computer-Assisted Treatment of Dual-Diagnosis Patients Robert J. Bischoff, Ph.D.
. B. Therapy Partner: A Computer-Assisted Psychotherapy Program Robert A. Bailey, M.D.
. C. Computer-Assisted Psychotherapy for Brief Treatment Groups Jerrold L. Shapiro, Ph.D.
.

S92. Current Perspectives on Psychiatry and Religion
A. A Cross-Cultural Perspective of Psychiatry and Religion Ronald M. Wintrob, M.D.
. B. Cults and New Religious Movements Marc Galanter, M.D.
. C. Religion and Psychiatry: Bioethics as Arbiter of Mutual Respect Laurence J. O'Connell, Ph.D., STD
. D. Psychiatry and Religion: Changes in Research and Training David B. Larson, M.D.
.

S93. Psychotherapies in Community Psychiatry Joint Session With the American Association of Community Psychiatrists
A. Psychotherapies in Community Psychiatry Clifton R. Tennison Jr., M.D.
. B. Psychotherapies and Psychosis Joel S. Feiner, M.D.
. C. Psychotherapy for People of Color With Serious Mental Illness Andres J. Pumariega, M.D.
. D. Family Psychoeducation: Outcome and Application William R. McFarlane, M.D.
. E. Biopsychosocial Treatments for Depressed Patients Gabor I. Keitner, M.D.
.

S94. Genetics of Personality and Behavior
A. Genetics of Personality and Behavior Kathleen R. Merikangas, Ph.D
.. B. The Genetic Structure of Personality Disorder Traits John Livesley, M.D.
. C. Gene Mapping of Human Personality Traits C. Robert Cloninger, M.D.
. D. Genetics of Antisocial Personality Disorder Remi J. Cadoret, M.D.
. E. Genetics of Schizotypal and BPD Larry J. Siever, M.D.
.